Literature DB >> 32758577

Traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the fruit of Tetradium ruticarpum: A review.

Manlin Li1, Changhong Wang2.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: The fruit of Tetradium ruticarpum (FTR) known as Tetradii fructus or Evodiae fructus (Wu-Zhu-Yu in Chinese) is a versatile herbal medicine which has been prescribed in Chinese herbal formulas and recognized in Japanese Kampo. FTR has been clinically used to treat various diseases such as headache, vomit, diarrhea, abdominal pain, dysmenorrhea and pelvic inflammation for thousands of years. AIM OF THE REVIEW: The present paper aimed to provide comprehensive information on the ethnopharmacology, phytochemistry, pharmacology, pharmacokinetics, drug interaction and toxicology of FTR in order to build up a foundation on the mechanism of ethnopharmacological uses as well as to explore the trends and perspectives for further studies.
MATERIALS AND METHODS: This review collected the literatures published prior to July 2020 on the phytochemistry, pharmacology, pharmacokinetics and toxicity of FTR. All relevant information on FTR was gathered from worldwide accepted scientific search engines and databases, including Web of Science, PubMed, Elsevier, ACS, ResearchGate, Google Scholar, and Chinese National Knowledge Infrastructure (CNKI). Information was also obtained from local books, PhD. and MSc. Dissertations as well as from Pharmacopeias.
RESULTS: FTR has been used as an herbal medicine for centuries in East Asia. A total of 165 chemical compounds have been isolated so far and the main chemical compounds of FTR include alkaloids, terpenoids, flavonoids, phenolic acids, steroids, and phenylpropanoids. Crude extracts, processed products (medicinal slices) and pure components of FTR exhibit a wide range of pharmacological activities such as antitumor, anti-inflammatory, antibacterial, anti-obesity, antioxidant, insecticide, regulating central nervous system (CNS) homeostasis, cardiovascular protection. Furthermore, bioactive components isolated from FTR can induce drug interaction and hepatic injury.
CONCLUSIONS: Therapeutic potential of FTR has been demonstrated with the pharmacological effects on cancer, inflammation, cardiovascular diseases, CNS, bacterial infection and obesity. Pharmacological and pharmacokinetic studies of FTR mostly focus on its main active alkaloids. Further in-depth studies on combined medication and processing approaches mechanisms, pharmacological and toxic effects not limited to the alkaloids, and toxic components of FTR should be designed.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antitumor; CYPs; Ethnopharmacology; Evodiamine; Hepatotoxicity; Tetradii fructus

Mesh:

Substances:

Year:  2020        PMID: 32758577     DOI: 10.1016/j.jep.2020.113231

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  13 in total

1.  Chemical Investigation of Tetradium ruticarpum Fruits and Their Antibacterial Activity against Helicobacter pylori.

Authors:  Myung Woo Na; Se Yun Jeong; Yoon-Joo Ko; Dong-Min Kang; Changhyun Pang; Mi-Jeong Ahn; Ki Hyun Kim
Journal:  ACS Omega       Date:  2022-06-28

Review 2.  Analgesic Alkaloids Derived From Traditional Chinese Medicine in Pain Management.

Authors:  Wei Jiang; Mingze Tang; Limin Yang; Xu Zhao; Jun Gao; Yue Jiao; Tao Li; Cai Tie; Tianle Gao; Yanxing Han; Jian-Dong Jiang
Journal:  Front Pharmacol       Date:  2022-05-10       Impact factor: 5.988

3.  Ethnopharmacological Survey of Traditional Chinese Medicine Pharmacy Prescriptions for Dysmenorrhea.

Authors:  Kuo-Han Su; Shan-Yu Su; Chien-Yu Ko; Yung-Chi Cheng; Shyh-Shyun Huang; Jung Chao
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

4.  Ethnoveterinary Survey Conducted in Baiku Yao Communities in Southwest China.

Authors:  Binsheng Luo; Qimin Hu; Kedao Lai; Arvind Bhatt; Renchuan Hu
Journal:  Front Vet Sci       Date:  2022-01-25

5.  Toxicity of Tetradium ruticarpum: Subacute Toxicity Assessment and Metabolomic Identification of Relevant Biomarkers.

Authors:  Qiyuan Shan; Gang Tian; Xin Han; Hui Hui; Mai Yamamoto; Min Hao; Jingwei Wang; Kuilong Wang; Xianan Sang; Luping Qin; Guanqun Chen; Gang Cao
Journal:  Front Pharmacol       Date:  2022-02-28       Impact factor: 5.810

6.  Active Ingredients from Euodia ruticarpa Steam Distilled Essential Oil Inhibit PC-3 Prostate Cancer Cell Growth via Direct Action and Indirect Immune Cells Conditioned Media In Vitro.

Authors:  Tzu-He Yeh; Jin-Yuarn Lin
Journal:  Curr Issues Mol Biol       Date:  2021-08-28       Impact factor: 2.976

7.  Simultaneous LC-MS/MS bioanalysis of alkaloids, terpenoids, and flavonoids in rat plasma through salting-out-assisted liquid-liquid extraction after oral administration of extract from Tetradium ruticarpum and Glycyrrhiza uralensis: a sample preparation strategy to broaden analyte coverage of herbal medicines.

Authors:  Manlin Li; Hanxue Wang; Xiaohan Huan; Ning Cao; Huida Guan; Hongmei Zhang; Xuemei Cheng; Changhong Wang
Journal:  Anal Bioanal Chem       Date:  2021-07-31       Impact factor: 4.142

8.  On the Inhibitability of Natural Products Isolated from Tetradium ruticarpum towards Tyrosine Phosphatase 1B (PTP1B) and α-Glucosidase (3W37): An In Vitro and In Silico Study.

Authors:  Dao-Cuong To; Thanh Q Bui; Nguyen Thi Ai Nhung; Quoc-Toan Tran; Thi-Thuy Do; Manh-Hung Tran; Phan-Phuoc Hien; Truong-Nhan Ngu; Phan-Tu Quy; The-Hung Nguyen; Huu-Tho Nguyen; Tien-Dung Nguyen; Phi-Hung Nguyen
Journal:  Molecules       Date:  2021-06-17       Impact factor: 4.411

Review 9.  Chinmedomics, a new strategy for evaluating the therapeutic efficacy of herbal medicines.

Authors:  Ying Han; Hui Sun; Aihua Zhang; Guangli Yan; Xi-Jun Wang
Journal:  Pharmacol Ther       Date:  2020-09-18       Impact factor: 12.310

10.  Simultaneous Qualitative and Quantitative Evaluation of the Coptidis Rhizoma and Euodiae Fructus Herbal Pair by Using UHPLC-ESI-QTOF-MS and UHPLC-DAD.

Authors:  Yan-Ying Li; Min-Qun Guo; Xue-Mei Li; Xiu-Wei Yang
Journal:  Molecules       Date:  2020-10-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.